| Financial Year |
March 31 2023 |
| Monetary Funds |
1,185,764,665.45 |
| Held-for-trading Financial Assets |
29,031,051.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
562,283,466.15 |
| Advances to Suppliers |
434,689,738.14 |
| Other Receivables |
190,856,246.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,237,651,158.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
158,675,578.63 |
| Total Current Assets |
5,274,774,206.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
143,141,363.26 |
| Long-term Equity Investment |
75,150,734.64 |
| Investment Properties |
-- |
| Fixed Assetes |
14,327,932,856.84 |
| Under-construction Projects |
610,372,318.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,577,307,702.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,292,885.29 |
| Deferred Income Tax Assets |
203,068,139.54 |
| Other Non-Current Assets |
28,324,200.00 |
| Sub-Total of Non-Current Assets |
18,008,255,110.81 |
| Total Assets |
23,283,029,317.63 |
| Short-Term Loans |
70,857,779.17 |
| Trading Financial liabilities |
516,447.00 |
| Notes Payable |
756,155,903.99 |
| Accounts Payable |
1,609,031,021.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
61,445,823.43 |
| Taxes Payable |
58,664,975.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
560,625,453.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,222,238,508.94 |
| Other Current Liabilities |
59,907,007.22 |
| Sub-Total of Current Liabilities |
4,893,218,617.35 |
| Long-term Loans |
1,289,985,607.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,743,196,368.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
360,565,653.62 |
| Deferred Income Tax Liabilities |
62,534,654.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,695,450,240.32 |
| Total Liabilities |
8,588,668,857.67 |
| Paid-In Capital(Or Share Stock) |
4,014,238,114.00 |
| Capital Surplus |
10,757,882,133.10 |
| Surplus Reserve |
253,518,251.82 |
| LESS:Treasury Stock |
197,348,500.00 |
| Undistributed Profits |
-2,480,307,911.81 |
| Minority Stockholder's Interest |
2,346,378,372.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,347,982,087.11 |
| Owner's Equity（Stockholder's Equity） |
14,694,360,459.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,283,029,317.63 |
